Skuratovskaia et al. reported that higher plasma IL-6 level was correlated with a decreased CRP level and IL-6R could reduce chronic inflammation in NAFLD (Skuratovskaia et al., 2021). Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.